ASSIMILA LIMITED
Company number 05967399 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Investment Risk Assessment: Assimila Limited (Company No. 05967399)
1. Risk Rating
LOW (solvency and liquidity basis) — with a MEDIUM caveat on information quality and operational concentration
On the evidence available, the company presents a strong balance-sheet profile: net assets of £790,228, cash of £743,252 and current liabilities of only £182,477 at 31 October 2025, implying a current ratio of approximately 5.3x and a cash-to-total-assets ratio of roughly 77%. There is no evidence of external borrowings, no overdue filings, and no insolvency or liquidation markers. The caveat is that the assessment is derived almost entirely from an unaudited, small-company balance sheet with no profit and loss account on public record; the absence of revenue, margin and customer data materially limits confidence in the operational dimension of the rating.
2. Key Concerns
2.1 Information opacity — no profit and loss disclosure The company files under the small companies regime (Total Exemption Full) and the accounts are explicitly unaudited, prepared under FRS 102 Section 1A. Only a balance sheet and abridged notes are on the public record. Turnover, gross margin, cost base, customer concentration and dividend policy are all unavailable. For an institutional investor, this is the single largest constraint: profitability can only be inferred from movements in retained earnings, which is an indirect and imperfect proxy (it conflates earnings with any distributions taken).
2.2 Key-person and ownership concentration Control sits with two individuals: name shown to subscribers (stated as holding more than 75% of shares and voting rights, with rights to appoint and remove directors) and name shown to subscribers (25–50%). name shown to subscribers also acts as both director and company secretary. A third director, name shown to subscribers, resigned on 20 August 2026, leaving a two-director board. For a research and consultancy business with only £7,952 of tangible fixed assets, enterprise value resides almost entirely in people, relationships and reputation — precisely the assets that are most vulnerable to departure. The resignation of a director is not in itself adverse, but it reduces board depth at a time when the company is otherwise thinly governed.
2.3 Earnings volatility and contract dependency Reconstructed retained-earnings movements show an uneven record:
| Year | Approx. retained earnings movement |
|---|---|
| FY2019 | −£190,322 (loss) |
| FY2020 | +£118,217 |
| FY2021 | +£95,928 |
| FY2022 | +£25,298 |
| FY2023 | +£26,592 |
| FY2024 | +£127,655 |
| FY2025 | +£84,699 |
Two observations follow. First, the FY2019 loss absorbed roughly 38% of the prior year's net assets — a reminder that the business model can swing sharply. Second, the near-flat years of FY2022 and FY2023 (returns of roughly 4–5% on equity) sit between much stronger years, consistent with a contract- or grant-funded revenue base with lumpy timing rather than recurring subscription income. This pattern is typical of research and consultancy work but is a genuine planning risk for an investor seeking predictable cash generation.
Supplementary observations (not ranked in the top three): - Sector classification mismatch: the registered SIC code (72190, other research and experimental development) does not match the accounts narrative, which states the principal activity is management consultancy. This affects peer benchmarking and may be relevant to grant eligibility or sector-specific regulation. - Creditor composition unknown: the £182,477 of current creditors could include deferred income on contracted work. If a material proportion is deferred revenue, the apparent liquidity cushion is partly an obligation to deliver services rather than a free reserve. - Data inconsistencies: the register records share capital of £100, whereas the accounts show £1,000 called-up share capital; FY2023 net assets (£578,874) and shareholders' funds (£577,874) differ by £1,000 in the supplied dataset. These are most likely extraction artefacts rather than substantive issues, but they should be reconciled. - PSC percentages: the stated holdings (75%+ and 25–50%) cannot both be arithmetically correct on a single class; the company has five ordinary share classes, so the position is probably class-specific. The articles and any shareholders' agreement should be reviewed.
3. Positive Indicators
- Genuine balance-sheet strength. Cash of £743,252 covers current liabilities 4.1 times over. Net current assets of £784,264 represent the overwhelming majority of net assets — the company is funded by its own reserves, not by creditors.
- No visible debt structure. No bank loans, overdrafts or finance leases are disclosed within creditors, and the only non-current liability is a £1,988 deferred tax provision. Interest-rate and covenant risk appear negligible.
- Consistent reserve accumulation. Shareholders' funds have risen from £402,819 (FY2016) to £790,228 (FY2025), an increase of approximately 96% over nine years, with only one loss-making year in that period. Retained earnings of £789,228 are entirely attributable to cumulative trading rather than revaluation or capital injection.
- Strong cash conversion. In most years, cash balances are equal to or exceed net assets, implying that working capital is self-funded and that reported profits are being converted into cash rather than absorbed by debtors or work-in-progress.
- Trading longevity. Incorporated in October 2006 and continuously active for approximately nineteen years, which is a meaningful survival signal in a sector with high failure rates among small research consultancies.
- Clean compliance record. Accounts and confirmation statement are both marked not overdue; the last accounts (year ended 31 October 2025) were approved on 3 March 2026, comfortably inside the nine-month deadline. No liquidation, administration, receivership or director disqualification data appears in the record.
- Asset-light, low capex model. Fixed assets of £7,952 mean minimal capital expenditure obligations and low operating leverage on the cost side — a business that can contract relatively quickly if revenue falls.
4. Due Diligence Notes
- Obtain full statutory accounts, including the profit and loss account and notes. Request several years of turnover, gross margin and operating profit directly from the company or its accountants (Carbon Accountancy Limited, Reading). The public file is insufficient for valuation or covenant analysis.
- Customer and contract concentration analysis. Establish the proportion of revenue derived from the top three to five clients, the split between grant-funded and commercially contracted work, and the identity of the principal funders (public bodies, research councils, agencies or corporates). Request the current order book and contracted backlog.
- Deferred income and revenue recognition. Ask for a breakdown of the £182,477 of current creditors, isolating deferred income, taxation and social security, accruals and any director loan accounts. Confirm the revenue recognition policy in full — the filed text is truncated before the policy detail.
- Ownership and governance review. Obtain the articles of association, any shareholders' agreement, and the register of members to reconcile the five ordinary share classes against the PSC declarations. Establish whether name shown to subscribers's rights confer genuine blocking or negative control, and whether any drag/tag or pre-emption provisions exist.
- Key-person and succession assessment. Clarify the circumstances of name shown to subscribers's resignation in August 2026, whether any further board changes are planned, and what key-person insurance, succession planning or non-compete arrangements are in place for the two remaining principals.
- Related-party and director transactions. Review notes for loans to directors, rent paid on behalf of or to principals, and any transactions with entities connected to the PSCs. None are visible in the truncated extract, but this should be confirmed.
- Charges register and asset security. Confirm at Companies House whether any charges or mortgages exist (none are evident in the accounts, but the register should be checked directly).
- Grant conditions and clawback exposure. If publicly funded, review grant agreements for clawback, state-aid or asset-lock provisions that could crystallise on a change of control — directly relevant to any acquisition or investment structure.
- Reconcile data discrepancies. Confirm the correct issued share capital (£100 vs £1,000) and the FY2023 reserves difference, and verify whether the SIC code should be updated to reflect the consultancy activity described in the accounts.
- Dividend history. Establish distributions made to the two shareholder-directors over the last five years, to distinguish genuine reinvestment from a business that is being run for owner-distribution rather than growth.